A Study of the Systemic Absorption of MOB015B
NCT03244280
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Onychomycosis
Interventions
DRUG:
MOB015B
Sponsor
Moberg Pharma AB